aminopyrine has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cramer, C; Ehdaivand, S; Lomme, MM; Price, LL; Sioshansi, S; Wazer, DE | 1 |
| DAUBNER, K; GATI, E; GODAN, F | 1 |
2 other study(ies) available for aminopyrine and Breast Neoplasms
| Article | Year |
|---|---|
Triple negative breast cancer is associated with an increased risk of residual invasive carcinoma after lumpectomy.
Topics: Adult; Aminopyrine; Breast Neoplasms; Drug Combinations; Female; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm, Residual; Phenylbutazone; Risk | 2012 |
[Development of bone marrow damage in connection with the treatment of breast cancer].
Topics: Agranulocytosis; Aminopyrine; Bone Marrow; Bone Marrow Diseases; Breast Neoplasms; Carcinoma; Carcinoma, Ductal; Humans; Radiation Injuries | 1962 |